Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
ADCT holding history
ADC Therapeutics SA in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADCT overviewAll 13F holders of ADCTFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −474,744−100.0% | Sold out | Holders |
| Q2 2024 | 474,744 | $1.50M | 0.2% | +474,744 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −1,013,540−100.0% | Sold out | Holders |
| Q4 2023 | 1,013,540 | $1.68M | 0.3% | −86,460−7.9% | Reduced | Holders |
| Q3 2023 | 1,100,000 | $986.7K | 0.3% | +500,000+83.3% | Added | Holders |
| Q2 2023 | 600,000 | $1.29M | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2023 | 600,000 | $1.17M | 0.4% | +600,000 | New | Holders |